| Pfizer AG - Xeljanz 10 mg, Filmtabletten | | 62630 | | 02 | | Xeljanz 10 mg | | Filmtabletten | | L04AF01 | | Tofacitinib | | 12.07.2013 | | |
| | Composition | | tofacitinibum 10 mg ut tofacitinibi citras, cellulosum microcristallinum, lactosum monohydricum 122.615 mg, carmellosum natricum conexum, magnesii stearas, Überzug: hypromellosum, E 171, lactosum monohydricum 2.52 mg, macrogolum 3350, triacetinum, E 132, E 133, pro compresso obducto, natrium max. 1.08 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Tofacitinibum | 10 mg |
| | BAG: Active Agent | Dose |
|---|
| Tofacitinibum | 10 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 132 | | color. | | E 133 | | color. | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 2.52 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Sodium | 1.08 mg | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 56 Tablet(s) | 690.40 | 763.40 | B | SL | No |
|
|
